Literature DB >> 2598758

Effect of antiandrogen flutamide on measures of hepatic regeneration in rats.

G W Svanas1, P K Eagon, M Elm, L Makowka, L Podesta, P Chapchap, D Kahn, T E Starzl, D H Van Thiel.   

Abstract

Male rat liver undergoes a process of demasculinization during hepatic regeneration following partial hepatectomy. The possibility that antiandrogens might potentiate this demasculinization process and in so doing augment the hepatic regenerative response was investigated. Adult male Wistar rats were treated with the antiandrogen flutamide (2 mg/rat/day or 5 mg/rat/day subcutaneously) or vehicle for three days prior to and daily after a 70% partial hepatectomy. At various times after hepatectomy, the liver remnants were removed and weighed. Rates of DNA and polyamine synthesis were assessed by measuring thymidine kinase and ornithine decarboxylase activities, respectively. Hepatic estrogen receptor status and the activity of alcohol dehydrogenase, an androgen-sensitive protein, were measured. Prior to surgery, the administration of 5 mg/day flutamide reduced the hepatic cytosolic androgen receptor activity by 98% and hepatic cytosolic estrogen receptor content by 92% compared to that present in vehicle-treated controls. After hepatectomy, however, all differences in sex hormone receptor activity between the treatment groups were abolished. The rate of liver growth after partial hepatectomy in the three groups was identical. Moreover, hepatectomy-induced increases in ornithine decarboxylase activity and thymidine kinase activity were comparable. These data demonstrate that, although flutamide administration initially alters the sex hormone receptor status of the liver, these affects have no effect on the hepatic regenerative response following a partial hepatectomy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2598758      PMCID: PMC2954617          DOI: 10.1007/BF01536712

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

1.  A biological profile of a nonsteroidal antiandrogen, SCH 13521 (4'-nitro-3'trifluoromethylisobutyranilide).

Authors:  R Neri; K Florance; P Koziol; S Van Cleave
Journal:  Endocrinology       Date:  1972-08       Impact factor: 4.736

2.  Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues.

Authors:  J Simard; I Luthy; J Guay; A Bélanger; F Labrie
Journal:  Mol Cell Endocrinol       Date:  1986-03       Impact factor: 4.102

3.  Control of estrogen binding protein concentration under basal conditions and after estrogen administration.

Authors:  M Sarff; J Gorski
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

4.  Nuclear localization of unoccupied oestrogen receptors.

Authors:  W V Welshons; M E Lieberman; J Gorski
Journal:  Nature       Date:  1984 Feb 23-29       Impact factor: 49.962

5.  Effects of castration and testosterone administration on rat liver alcohol dehydrogenase activity.

Authors:  E Mezey; J J Potter; S M Harmon; P D Tsitouras
Journal:  Biochem Pharmacol       Date:  1980-12-01       Impact factor: 5.858

6.  Ornithine decarboxylase activity and the onset of deoxyribonucleic acid synthesis in regenerating liver.

Authors:  J A McGowan; N Fausto
Journal:  Biochem J       Date:  1978-01-15       Impact factor: 3.857

7.  Studies on mechanisms of ornithine decarboxylase activity regulation in regenerating liver.

Authors:  M F Zuretti; E Gravela; F Papino; L Sartorio
Journal:  Cell Biochem Funct       Date:  1985-04       Impact factor: 3.685

8.  Sex steroid induced changes in hepatic enzymes.

Authors:  J A Gustafsson; A Mode; G Norstedt; P Skett
Journal:  Annu Rev Physiol       Date:  1983       Impact factor: 19.318

Review 9.  Polyamine metabolism and function.

Authors:  A E Pegg; P P McCann
Journal:  Am J Physiol       Date:  1982-11

10.  Continuous infusion of growth hormone feminizes hepatic steroid metabolism in the rat.

Authors:  A Mode; G Norstedt; B Simic; P Eneroth; J A Gustafsson
Journal:  Endocrinology       Date:  1981-06       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.